Avantax Advisory Services’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-448
Closed -$11.3K 1694
2023
Q3
$11.3K Hold
448
﹤0.01% 1537
2023
Q2
$62.2K Sell
448
-2
-0.4% -$257 ﹤0.01% 1464
2023
Q1
$41K Hold
450
﹤0.01% 1456
2022
Q4
$61.7K Sell
450
-2
-0.4% -$677 ﹤0.01% 1377
2022
Q3
$392K Hold
452
0.01% 889
2022
Q2
$198K Sell
452
-2
-0.4% -$1.04K ﹤0.01% 1211
2022
Q1
$290K Buy
454
+1
+0.2% +$630 ﹤0.01% 1018
2021
Q4
$404K Buy
453
+5
+1% +$5.25K 0.01% 837
2021
Q3
$568K Buy
+448
New +$543K 0.01% 675

Other funds holding CANO

Avantax Advisory Services's CANO Position: Q4 2023 in Review

Avantax Advisory Services sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 448 shares — an estimated $11.3K sold.

Avantax Advisory Services first reported a position in CANO in Q3 2021 and held it in 9 quarters. The position peaked at $568K in Q3 2021. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Avantax Advisory Services reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Avantax Advisory Services sold 448 Cano Health, Inc. shares in Q4 2023, an estimated $11.3K.
  • Avantax Advisory Services first reported a position in Cano Health, Inc. in Q3 2021 and held it in 9 quarters.
  • Avantax Advisory Services's Cano Health, Inc. position peaked at $568K in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Avantax Advisory Services's 13F filing for Q4 2023, filed 7 Feb 2024.